03696

30.6008.55%
AZ

Aleksandrs Zhavoronkov

Founder, CEO, Chief Business Officer, Longevity Board Member & Chairman of the Board

Dr. Aleksandrs Zhavoronkov, Ph.D., also known as Alex, is Founder, Chief Executive Officer, Chief Business Officer & Chairman of the Board of InSilico Medicine Cayman TopCo from February 2014 and serves as its Member of Longevity Board from April 2026. Dr. Zhavoronkov joined the InSilico Medicine Cayman TopCo in February 2014. Dr. Zhavoronkov is Founder, Chairman & CEO of Insilico Medicine, Inc. Dr. Zhavoronkov is a Principal of Juvenescence AI. For several years now, he has been head of the Regenerative Medicine Laboratory at the Centre for Pediatric Hematology, Oncology and Immunology and adjunct professor at the Institute of Physics and Technology in Moscow. He is the Chief Scientific Officer of the Biogerontology Research Foundation. He is also the director of the International Aging Research Portfolio (IARP) knowledge management project, chief scientist of Youth Laboratories and the adjunct professor of the Moscow Institute of Physics and Technology. He serves as Investment Partner at ETP China. He is the author of over 90 research publications in the peer-reviewed journals and books including "The Ageless Generation: How advances in biomedicine transform the global economy" (Palgrave Macmillan, 2013) and “Dating AI: A Guide to Falling in Love with Artificial Intelligence” (RE/Search, 2012). Prior to switching his focus to ageing research in 2004, he worked as the director of ATI Technologies, a major Canadian GPU company and was the co-founder and CSO of NeuroG, a neuroinformatics company. He has been engaged in drug discovery and aging research with GAN and reinforcement learning. He is the editor of numerous journals including Ageing and Oncotarget: Gerotarget, associate editor of Frontiers in Genetics and review editor of Frontiers in Molecular Biosciences. He also is co-organizing the annual Aging Research for Drug Discovery Forum and the annual Artificial Intelligence & Blockchain for Healthcare Forum in Basel, Switzerland as part of EMBO/Basel Life congress. Dr. Zhavoronkov completed his Ph.D. in physics and mathematics from Lomonosov Moscow State University in October 2008, an MSc in biotechnology from Johns Hopkins University in May 2007, Dr. Zhavoronkov received two bachelor’s degrees in commerce and science from Queen’s University in Canada in May and June 2001.

Positions